Fig. 5From: Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory propertiesChemokine expression profile in astrocytes exposed to medium and Th1 or Th17 supernatants. Fold changes in CCL2, CCL20, CXCL10, and CXCL12 mRNA expression in Th1- and Th17-treated astrocytes compared to medium control were measured by RT-PCR. The results are mean ± SEM with *p ≤ 0.05 and **p ≤ 0.01 of a minimum of four independent experiments (n = 4)Back to article page